Oncology care management helps coordinate the clinical aspects of cancer treatment, but it would also be helpful to have a benefits manager to help guide patients through their many options, said Marianne Fazen, PhD, president and CEO of the Texas Business Group on Health.
Oncology care management helps coordinate the clinical aspects of cancer treatment, but it would also be helpful to have a benefits manager to help guide patients through their many options, said Marianne Fazen, PhD, president and CEO of the Texas Business Group on Health.
Transcript (slightly modified)
Do employers see value in participating in the Oncology Care Model?
Yes, of course. Oncology care management is a wonderful service, and helps coordinate a lot of the clinical side of it. But I’ll tell you what’s really needed besides the care management. It’s somebody at the workplace who understands all the different resources and benefits are available. It’s hard for a benefits manager to know where to find where all the policies are and programs.
They can make coverage decisions really well and plan to sign and send us to go see this group of oncologists or go to this particular center of excellence. But to have somebody at the worksite who actually knows what the patient needs and knows all the different programs, policies, what the health plan offers and all that, would be just almost like the dream come true for a lot of employers and it’s something that most of them do not have.
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More